103 related articles for article (PubMed ID: 33794055)
1. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
2. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
Banegas MP; Harlan LC; Mann B; Yabroff KR
Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
[TBL] [Abstract][Full Text] [Related]
3. Patients with high nuclear grade pT1-ccRCC are more suitable for radical nephrectomy than partial nephrectomy: a multicenter retrospective study using propensity score.
Xu H; Xing Z; Ai K; Wang J; Lv Z; Deng H; Li K; Wang Y; Li Y
World J Surg Oncol; 2024 Jan; 22(1):24. PubMed ID: 38254091
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database.
Choi C; Kang M; Seo SI; Suh J; Song C; Chung J; Kim SH; Park JY; Hwang EC; Jeong CW; Kwak C; Kim JK; Hong SH
J Korean Med Sci; 2024 Jan; 39(3):e11. PubMed ID: 38258358
[TBL] [Abstract][Full Text] [Related]
5. Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors.
Marchiñena PG; Tirapegui S; Gonzalez IT; Jurado A; Gueglio G
Int Braz J Urol; 2018; 44(3):475-482. PubMed ID: 29368873
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of partial versus radical nephrectomy for renal cell carcinoma: Is oncologic safety compromised during nephron sparing in higher stage disease?
Hakam N; Heidar NA; El-Asmar J; Khauli M; Degheili J; Al-Moussawy M; Nasr R; El-Hajj A; Wazzan W; Bulbul M; Khauli RB
Urol Ann; 2023; 15(2):226-231. PubMed ID: 37304513
[TBL] [Abstract][Full Text] [Related]
7. [Long-term survival analysis of 1 367 patients treated with radical nephrectomy from a single center].
Zou XP; Ning K; Zhang ZL; Zou L; Xiong LB; Peng YL; Zhou ZH; Liu HM; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):981-987. PubMed ID: 37968085
[No Abstract] [Full Text] [Related]
8. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
Talenfeld AD; Gennarelli RL; Elkin EB; Atoria CL; Durack JC; Huang WC; Kwan SW
Ann Intern Med; 2018 Jul; 169(2):69-77. PubMed ID: 29946703
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract][Full Text] [Related]
10. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.
Liu Z; Yang Z; Li J; Liu Z; Ma N; Chen P; Bi X; Li Z; Dong P; Han H; He X; Mao X; Guo S
Asian J Surg; 2023 Sep; 46(9):3607-3613. PubMed ID: 37147255
[TBL] [Abstract][Full Text] [Related]
11. [Oncological results of repeat partial nephrectomy in patients with recurrence after nephron-sparing procedures].
Matveev V B; Zhumabaev N K; Komarov M I; Klimov A V; Stilidi I S
Urologiia; 2024 Mar; (1):86-91. PubMed ID: 38650411
[TBL] [Abstract][Full Text] [Related]
12. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
[TBL] [Abstract][Full Text] [Related]
13. Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension.
Filson CP; Schwartz K; Colt JS; Ruterbusch J; Linehan WM; Chow WH; Miller DC
Urol Oncol; 2014 Jan; 32(1):27.e15-21. PubMed ID: 23419677
[TBL] [Abstract][Full Text] [Related]
14. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
Scilipoti P; Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Musso G; Cei F; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
World J Urol; 2024 Apr; 42(1):264. PubMed ID: 38676733
[TBL] [Abstract][Full Text] [Related]
15. Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma.
Kröger Dahlin BI; Hlodan J; Ghaffarpour R; Ljungberg B
Scand J Urol; 2024 Feb; 59():26-30. PubMed ID: 38358280
[TBL] [Abstract][Full Text] [Related]
16. Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.
Blum KA; Silagy AW; Knezevic A; Weng S; Wang A; Mano R; Marcon J; DiNatale RG; Sanchez A; Tickoo S; Gupta S; Motzer R; Haas NB; Kim SE; Uzzo RG; Coleman JA; Hakimi AA; Russo P
BJU Int; 2024 Feb; 133(2):169-178. PubMed ID: 37589200
[TBL] [Abstract][Full Text] [Related]
17. Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy.
Khaleel S; Truong H; Jiang S; K-Lee P; Davelman B; Gordon D; Benfante N; Arora A; Ostrovnaya I; Tickoo S; Coleman J; Hakimi AA; Russo P
Urol Oncol; 2023 Sep; 41(9):391.e5-391.e11. PubMed ID: 37423816
[TBL] [Abstract][Full Text] [Related]
18. Prediction of clinically significant recurrence after partial nephrectomy. Data from the Cancer Registry of Norway with more than five years of follow-up.
Barnoiu OS; Johannesen TB; Diep LM; Pedersen ES; Hjelle KM; Beisland C
Scand J Urol; 2024 Jan; 59():1-9. PubMed ID: 38226773
[TBL] [Abstract][Full Text] [Related]
19. Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.
Xing Z; Xu H; Ai K; Deng H; Hong Y; Deng P; Wang J; Xiong W; Li Z; Zhu L; Li Y
Ann Surg Oncol; 2024 May; 31(5):3531-3543. PubMed ID: 38329657
[TBL] [Abstract][Full Text] [Related]
20. Computer tomography-based shape of tumor contour and texture of tumor heterogeneity are independent prognostic indicators for clinical T1b-T2 renal cell carcinoma.
Song B; Hwang SI; Lee HJ; Lee H; Oh JJ; Lee S; Hong SK; Byun SS; Kim JK
World J Urol; 2023 Oct; 41(10):2723-2734. PubMed ID: 37530807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
